뉴냅스는 식품의약품안전처로부터 시야장애 개선을 위한 디지털 약 뉴냅비전의 임상시험 승인을 받았다고 1일 발표했다.
Nunaps announced on the 1st that it has received approval from the Ministry of Food and Drug Safety for clinical trials of the digital drug Nunap Vision to improve visual impairment.